In 2021, poison centres fielded around 100 calls a month linked to these medications
Appetite for Ozempic wanes Three months after semaglutide went off-patent, the excitement around the weight-loss drug is tapering off while tirzepatide, marketed as Mounjaro, is regaining its GLP-1 market share Three months after the patent on semaglutide (the active ingredient in Novo Nordisks diabetes and weight-loss drugs like Ozempic and Wegovy) expired, the excitement around the anti-obesity drug seems to be tapering off
You should only add berberine to a compounded semaglutide program after consulting with your healthcare provider
Urgent Symptoms Some problems are uncommon but important
Nausea, vomiting, and gastrointestinal discomfort are reported more often by female patients, she explains
Unlike older drugs that focus on just one hormone, retatrutide acts on three: GLP-1, GIP, and glucagon